Is topical antibiotic use necessary to prevent surgical site infection following oculoplastic surgery?

PURPOSE: To assess whether oculoplastic surgeries can be performed without any topical and systemic antibiotics, in a "100% antibiotic free" fashion. METHOD: We conducted a multicenter retrospective study between November 2017 and December 2022. Patients who underwent an oculoplastic procedure were screened. Patients who received preoperative or postoperative systemic antibiotics were excluded. Intraoperative IV antibiotics were allowed. Patients were divided into two groups: those who were treated with local antibiotics ointments (LATB group) and those who were treated without local antibiotics ointments (LATB free group) postoperatively. The primary outcome was the incidence of surgical site infections (SSI). The relationship between the use of local antibiotics and the occurrence of SSI was assessed using Fisher's exact test. The alpha risk was set to 5% and two-tailed tests were used. RESULTS: Among the 947 procedures included, 617 were included in the LATB group and 330 in the LATB free group. 853 and 80 procedures were classified Altemeier class 1 (clean) and class 2 (clean-contaminated) surgeries, respectively. Overall, 310 (32.73%) procedures were performed without any systemic nor topical antibiotics (100% antibiotic free fashion). SSI occured in four (4/617; 0.65%) and five (5/330; 1.52%) procedures in the LATB and LATB free group respectively, without any statistical difference between the groups (p = 0.290). A subgroup analysis was carried out by excluding the procedures performed under prophylactic intraoperative intravenous antibiotics and did not reveal any statistical difference between the two groups (p = 0.144). All SSI patients were treated with systemic antibiotics with favorable outcomes. Postoperative wound dehiscence was the only risk factor associated with postoperative SSI (p = 0.002). CONCLUSION: This study suggests that performing a "100% antibiotic free" oculoplastic surgery without systemic and topical antibiotics is reasonable in Altemeier class 1 and class 2 procedures.

Designing of WO3@Co3O4 Heterostructures to Enhance Photoelectrochemical Performances.

Heterostructured photocatalysts are superior to single photocatalysts because they offer better charge separation and broaden light harnessing abilities. Although WO3 is considered an oxygen-evolving photocatalyst with decent stability and proper band gap, its lower photocatalytic efficiency is ascribed to high charge recombination. In this research, a WO3@Co3O4 heterostructure reduced the recombination of photocatalytic charges and extended light absorption abilities, resulting in improved photocatalytic activity. The presence of Co3O4 nanoparticles improved light absorption and charge transfer of tungsten oxide films for photoelectrochemical reactions. For photoelectrochemical water oxidation, WO3@Co3O4 nanostructures generated a photocurrent 20 times higher than that of pure WO3. Both electrodeposition and sol gel techniques were utilized to synthesize the WO3@Co3O4 photoelectrode. Scanning electron microscopy and X-ray diffraction were used to characterize the formation of the above photocatalyst. A photocurrent study was done to investigate the charge separation mechanism to explain the enhanced photocatalytic activity.